HomeCompareSBMFF vs PEP

SBMFF vs PEP: Dividend Comparison 2026

SBMFF yields 1.32% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $113.2K in total portfolio value· pulled ahead in Year 2
10 years
SBMFF
SBMFF
● Live price
1.32%
Share price
$0.76
Annual div
$0.01
5Y div CAGR
27.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.8K
Annual income
$2,017.55
Full SBMFF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — SBMFF vs PEP

📍 PEP pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBMFFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBMFF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBMFF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBMFF
Annual income on $10K today (after 15% tax)
$111.99/yr
After 10yr DRIP, annual income (after tax)
$1,714.92/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $50,879.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBMFF + PEP for your $10,000?

SBMFF: 50%PEP: 50%
100% PEP50/50100% SBMFF
Portfolio after 10yr
$85.3K
Annual income
$31,946.62/yr
Blended yield
37.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

SBMFF
No analyst data
Altman Z
3.2
Piotroski
7/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBMFF buys
0
PEP buys
0
No recent congressional trades found for SBMFF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBMFFPEP
Forward yield1.32%3.63%
Annual dividend / share$0.01$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR27.4%40.4%
Portfolio after 10y$28.8K$141.9K
Annual income after 10y$2,017.55$61,875.67
Total dividends collected$7.6K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: SBMFF vs PEP ($10,000, DRIP)

YearSBMFF PortfolioSBMFF Income/yrPEP PortfolioPEP Income/yrGap
1$10,868$167.85$10,849$509.42+$19.00SBMFF
2← crossover$11,846$217.20$11,969$750.47$123.00PEP
3$12,957$281.88$13,500$1,124.14$543.00PEP
4$14,231$367.10$15,680$1,721.66$1.4KPEP
5$15,707$480.07$18,929$2,715.34$3.2KPEP
6$17,438$630.89$24,023$4,450.80$6.6KPEP
7$19,492$833.93$32,510$7,669.92$13.0KPEP
8$21,967$1,109.91$47,709$14,093.60$25.7KPEP
9$24,993$1,489.27$77,415$28,083.48$52.4KPEP
10$28,761$2,017.55$141,922$61,875.67$113.2KPEP

SBMFF vs PEP: Complete Analysis 2026

SBMFFStock

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Full SBMFF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this SBMFF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBMFF vs SCHDSBMFF vs JEPISBMFF vs OSBMFF vs KOSBMFF vs MAINSBMFF vs MOSBMFF vs PMSBMFF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.